Cargando…

BRCA Genetic Test and Risk-Reducing Salpingo-Oophorectomy for Hereditary Breast and Ovarian Cancer: State-of-the-Art

SIMPLE SUMMARY: The BRCA genetic test and HRD (homologous recombination deficiency) test are used as a companion diagnosis before starting PARP (poly ADP-ribose polymerase) inhibitor treatment. In clinical practice, gynecologists treating ovarian cancer are faced with decisions such as whether to re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sekine, Masayuki, Nishino, Koji, Enomoto, Takayuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197088/ https://www.ncbi.nlm.nih.gov/pubmed/34071148 http://dx.doi.org/10.3390/cancers13112562

Ejemplares similares

Differences in age at diagnosis of ovarian cancer for each BRCA mutation type in Japan: optimal timing to carry out risk-reducing salpingo-oophorectomy
por: Sekine, Masayuki, et al.
Publicado: (2022)

Impact of lower co-payments on risk-reducing salpingo-oophorectomy and BRCA testing in Japan
por: Konnai, Katsuyuki, et al.
Publicado: (2023)

Differences in Ovarian and Other Cancers Risks by Population and BRCA Mutation Location
por: Sekine, Masayuki, et al.
Publicado: (2021)

A prospective multicentric study of risk-reducing salpingo-oophorectomy in BRCA mutation patients
por: Loizzi, Vera, et al.
Publicado: (2022)

Contralateral ovarian endometrioma recurrence after unilateral salpingo-oophorectomy
por: Hidari, Tokie, et al.
Publicado: (2019)

Impact of the coverage of risk-reducing salpingo-oophorectomy by the national insurance system for women with BRCA pathogenic variants in Japan
por: Nomura, Hidetaka, et al.
Publicado: (2023)

Trends in Risk-Reducing Mastectomy and Risk-Reducing Salpingo-Oophorectomy in Korean Carriers of the BRCA1/2 Mutation
por: Jung, Sung Mi, et al.
Publicado: (2020)

Laparoscopic Salpingo-oophorectomy in Conscious Sedation
por: Rosati, Maurizio, et al.
Publicado: (2015)

Meta-analysis of Risk Reduction Estimates Associated With Risk-Reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation Carriers
por: Rebbeck, Timothy R., et al.
Publicado: (2009)

An explainable machine learning ensemble model to predict the risk of ovarian cancer in BRCA-mutated patients undergoing risk-reducing salpingo-oophorectomy
por: Comes, Maria Colomba, et al.
Publicado: (2023)

Bone density loss after risk reducing salpingo-oophorectomy
por: Andrews, L, et al.
Publicado: (2012)

Cost effectiveness of bilateral risk-reducing mastectomy and salpingo-oophorectomy
por: Schrauder, Michael G., et al.
Publicado: (2019)

Transvaginal laparoscopic salpingo-oophorectomy: an oncological risk-reducing procedure
por: Lathouras, Kostas, et al.
Publicado: (2019)

Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers
por: Marchetti, Claudia, et al.
Publicado: (2014)

Selected features of breast and peritoneal cancers diagnosed in BRCA1 carriers after risk-reducing salpingo-oophorectomy
por: Menkiszak, Janusz, et al.
Publicado: (2019)

Bilateral Salpingo-oophorectomy and Breast Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Assessing the Evidence
por: Conduit, Ciara, et al.
Publicado: (2021)

Risk-reducing salpingo-oophorectomy among Chinese women at increased risk of breast and ovarian cancer
por: Feng, Zheng, et al.
Publicado: (2023)

Prophylactic salpingo-oophorectomy in BRCA1 mutation carriers and postoperative incidence of peritoneal and breast cancers
por: Menkiszak, Janusz, et al.
Publicado: (2016)

Hormone Levels and Sexual Functioning After Risk-Reducing Salpingo-Oophorectomy
por: Johansen, Nora, et al.
Publicado: (2018)

Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers
por: Mavaddat, Nasim, et al.
Publicado: (2020)

Changes in Bone Mineral Density After Prophylactic Bilateral Salpingo-Oophorectomy in Carriers of a BRCA Mutation
por: Kotsopoulos, Joanne, et al.
Publicado: (2019)

Factors associated with the decision to undergo risk-reducing salpingo-oophorectomy among women at high risk for hereditary breast and ovarian cancer: a systematic review
por: Park, Sun-young, et al.
Publicado: (2020)

Surgical decision making in premenopausal BRCA carriers considering risk-reducing early salpingectomy or salpingo-oophorectomy: a qualitative study
por: Gaba, Faiza, et al.
Publicado: (2022)

The Psychosocial Impact of the Decision to Undergo Risk-Reducing Salpingo-Oophorectomy Surgery in BRCA Mutation Carriers and the Role of Physician-Patient Communication
por: Alves-Nogueira, Ana C., et al.
Publicado: (2023)

Correction to: Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers
por: Mavaddat, Nasim, et al.
Publicado: (2020)

The Effect of Risk-Reducing Salpingo-Oophorectomy on Breast Cancer Incidence and Histopathological Features in Women with a BRCA1 or BRCA2 Germline Pathogenic Variant
por: Stuursma, Annechien, et al.
Publicado: (2023)

“Best practices in risk reducing bilateral salpingo-oophorectomy: the influence of surgical specialty”
por: Malacarne, Dominique R., et al.
Publicado: (2017)

Cholesterol profile in women with premature menopause after risk reducing salpingo-oophorectomy
por: Teixeira, Natalia, et al.
Publicado: (2018)

Role of Routine Peritoneal Biopsies During Risk Reducing Salpingo-Oophorectomy (RRSO)
por: Pross, Therese, et al.
Publicado: (2021)

Risk-reducing Salpingo-oophorectomy consults and practices during the COVID-19 pandemic
por: O'Mara, A.E., et al.
Publicado: (2022)

Malignant neoplasia arising from ovarian remnants following bilateral salpingo-oophorectomy (Review)
por: IMAI, ATSUSHI, et al.
Publicado: (2014)

Metastatic ovarian carcinoma in breast cancer patients during risk-reducing salpingo-oophorectomy: Report of two cases
por: Shakya, Prafulla, et al.
Publicado: (2021)

Combined Bilateral Salpingo-oophorectomy and Cesarean Delivery in BRCA1/2 Alteration Carriers: A Case Series
por: Barker, Victoria E., et al.
Publicado: (2023)

Penetrance of Breast and Ovarian Cancer in Women Who Carry a BRCA1/2 Mutation and Do Not Use Risk-Reducing Salpingo-Oophorectomy: An Updated Meta-Analysis
por: Chen, Jinbo, et al.
Publicado: (2020)

Cytologic studies of the fallopian tube in patients undergoing salpingo-oophorectomy
por: Chen, Hao, et al.
Publicado: (2016)

Analysis of Prophylactic Salpingo-oophorectomy at the Time of Hysterectomy for Benign Lesions
por: Jain, Sheela Hemant, et al.
Publicado: (2019)

Bilateral Salpingo-Oophorectomy for Intracardiac Leiomyomatosis: A Case Report
por: Liang, Jinxiao, et al.
Publicado: (2022)

Elevated Bone Turnover Markers after Risk-Reducing Salpingo-Oophorectomy in Women at Increased Risk for Breast and Ovarian Cancer
por: Fakkert, Ingrid E., et al.
Publicado: (2017)

High-Grade Serous Carcinoma at Risk-Reducing Salpingo-Oophorectomy in Asymptomatic Carriers of BRCA1/2 Pathogenic Variants: Prevalence and Clinical Factors
por: Stroot, Iris A.S., et al.
Publicado: (2023)

Uptake of risk-reducing salpingo-oophorectomy in women carrying a BRCA1 or BRCA2 mutation: evidence for lower uptake in women affected by breast cancer and older women
por: Sidon, L, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_o7blcn165rmirn4h6e3gp4luuf